Dark

RGC
Regencell Bioscience Holdings Limited
stock NASDAQ

At Close

May 15, 2025 3:59:30 PM EDT

399.00USD-0.746%(-3.00)35,090

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 12, 2025 9:19:30 AM EDT

450.00USD+11.940%(+48.00)0

After-hours

May 13, 2025 4:23:30 PM EDT

296.59USD-8.461%(-27.42)0

Overview HistoricalExchangesShortsMore

open chart

Market Cap

5.26B

Headquarters

TN, USA

Industry

Drug Manufacturers-Specialty & Generic

RDI MCS CNK AMC

RGC Stats

Avg. Vol. 10 Day

153,367

Avg. Vol. 30 Day

116,623

Employees

26,000

Market Cap

5,263,704,297

Shares Out.

13,012,866

On/Off Exchange

54%/46%

6 Month Beta

-1.28

1 Year Beta

-1.06

2 Year Beta

-0.81

3 Year Beta

-0.61

52 Week Low

3.03

52 Week High

550.00

SMA50

75.57

SMA200

23.31

1 Week

+10.52%

1 Month

+1,384.40%

3 Month

+10,832.43%

6 Month

+6,498.70%

1 Year

+7,663.92%

2 Year

+1,570.80%

5 Year

+3,752.38%

Profile

we are an early-stage bioscience company that focuses on research, development and commercialization of tcm for the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder ("adhd"), autism spectrum disorder ("asd") in infectious diseases such as covid-19. our goal is to improve the lives of adhd, asd and covid patients, their families and caregivers and become a market leader for the best tcm treatment globally.

RGC Stock Summary

Regencell Bioscience Holdings Limited (NASDAQ:RGC) stock price today is $399.00, and today's volume is 35,090. RGC is down -0.746% today. The 30 day average volume is 116,623. RGC market cap is 5.26B with 13,012,866 shares outstanding.